Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis

E-ISSN： 1873-4286|17|3|204-214

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.3, 2011-01, pp. : 204-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia

By Matsuzaki Shinsuke Tohyama Masaya

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1097-1108

Informa Healthcare

Access to resources Recommend Favorite

Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord

By Narita M. Dun S.L. Dun N.J. Tseng L.F.

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite

Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 4, 2015-05 ,pp. : 540-553

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs

By Seki Y. Suzuki Y. Baskaya M.K. Kano T. Saito K. Takayasu M. Shibuya M. Sugita K.

European Journal of Pharmacology, Vol. 275, Iss. 3, 1995-03 ,pp. : 259-266

Elsevier

Access to resources Recommend Favorite

Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart

By Hirose M. Furukawa Y. Lakhe M. Chiba S.

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 269-276

Elsevier

Access to resources Recommend Favorite